Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune Memory After Papillomavirus Vaccination (IMAP-1)

This study has been completed.
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Mark Mulligan, Emory University
ClinicalTrials.gov Identifier:
NCT01505049
First received: January 4, 2012
Last updated: July 20, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)